Second Generation Antipsychotic Sheet
3—©2014‐2017 Magellan Health, Inc. v Leucht S., Komossa K, Rummel-Kluge C, et al. (2009). Meta-Analysis of Head-to Head Comparisons of Second Generation Antipsychotics in the Treatment of Schizophrenia.
Download Second Generation Antipsychotic Sheet
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Using Correct License-level Modifiers on Your Claims
www.magellanprovider.com©2005-2018 Magellan Health, Inc. Last reviewed 2/2018 Using Correct License-level Modifiers on Your Claims Magellan organizational providers and individual providers submitting professional (CPT) claims as part of an organization (using the organization’s Taxpayer Identification Number) must submit claims with the license-level modifier that …
Using, License, Levels, Correct, Using correct license level modifiers on, Modifiers
Coordination of Benefits - Magellan Provider
www.magellanprovider.comCoordination of Benefits Coordination of Benefits Magellan coordinates benefits with other payers when a member is covered by two or more group health benefit plans.
Benefits, Provider, Coordination, Magellan, Coordination of benefits, Magellan provider, Coordination of benefits coordination of benefits
2018 Handbook for the National Provider Network
www.magellanprovider.comNational Provider Network Handbook 4—© 2000-2018 Magellan Health, Inc. 11/17 Case Management Member Rights and Responsibilities Magellan Clinical Practice Guidelines
Network, Practices, Handbook, National, Provider, Handbook for the national provider network
Policy and Standards - Magellan Provider
www.magellanprovider.comFALSE CLAIMS LAWS AND WHISTLEBLOWER PROTECTIONS Page 1 of 23 —PROPRIETARY Magellan Health policies apply to all subsidiaries and affiliates, including but not limited to Magellan Healthcare, …
Treatment Record Review Tool - Magellan Provider
www.magellanprovider.comTreatment Record Review Tool This is the standard review tool used for all behavioral health records. Additional indicators may be included based on regulatory and/or customer requirements.
Review, Treatment, Record, Behavioral, Tool, Provider, Magellan, Magellan provider, Treatment record review tool
Authorization to Use or Disclose Protected Health ...
www.magellanprovider.comLast Updated: 03/10/07 Authorization to Disclose Protected Health Information to Primary Care Physician Communication between your behavioral health provider(s) and your primary care physician (PCP) is important to make sure all care is complete,
Health, Information, Authorization, Protected, Disclose, Authorization to use or disclose protected health, Disclose protected health information
Magellan’s Update of its Introduction to the …
www.magellanprovider.com© 2005-2017 Magellan Health, Inc. This document is the proprietary information of Magellan Health, Inc. and its affiliates. 6/17 Magellan’s Update of its Introduction to the American Psychiatric Association’s Clinical Practice Guideline
American, Guidelines, Practices, Association, Psychiatric, Practice guidelines, American psychiatric association
Organization & Facility Handbook Supplement
www.magellanprovider.comOrganizational and Facility Provider Handbook Supplement 2—© 2004-2018 Magellan Health, Inc. 11/17 Table of Contents SECTION 1: INTRODUCTION ..... 4
1. HOSPITALIZATION - Hospitalization is the highest …
www.magellanprovider.comMAGELLAN UNIVERSAL SERVICES LIST - Includes Preferred HIPAA Compliant Codes 3.1 Partial Hospitalization, Psychiatric. Assists individuals who …
2018 Handbook for the National Provider Network
www.magellanprovider.comNational Provider Network Handbook 4—© 2000-2018 Magellan Health, Inc. 11/17 Case Management Member Rights and Responsibilities Magellan Clinical Practice Guidelines
Network, Management, Handbook, National, Provider, Handbook for the national provider network
Related documents
QUICK REFERENCE TO PSYCHOTROPIC MEDICATIONS
psyd-fx.comasenapine Saphris 10-20 mg low low + + 1-2 mg lurasidone Latuda 40-80 mg mid mid + + 10 mg aripiprazole Abilify 15-30mg low low + + 2 mg Consumer’s Guide to Psychiatric Drugs (2009) Preston, O’Neal, Talaga Child and Adolescent Psychopharmacology Made Simple (2010) Preston, O’Neal, Talaga 1Usual daily oral dosage
QUICK REFERENCE TO PSYCHOTROPIC MEDICATIONS
www.continuingedcourses.netasenapine Saphris 10-20 mg low low + + 1-2 mg lurasidone Latuda 40-80 mg mid mid + + 10 mg aripiprazole Abilify 15-30mg low low + + 2 mg Consumer’s Guide to Psychiatric Drugs (2009) Preston, O’Neal, Talaga Child and Adolescent Psychopharmacology Made Simple (2010) Preston, O’Neal, Talaga 1Usual daily oral dosage
Reference, Parish, Quick, Psychotropic, Quick reference to psychotropic
DOSING AND TITRATION OF COMMONLY USED …
media.empr.comSaphris (asenapine SL tabs) Schizophrenia Acute: 5mg twice daily Maintenance: 5mg twice daily Acute: 5mg twice daily; max 20mg/day Maintenance: 10mg twice daily; max 20mg/day Maintenance: Increase to max 10mg twice daily after 1 week Seroquel (quetiapine fumarate tabs) Schizophrenia 25mg twice daily on day 1; increase by 25–50mg 2–3
Used, Parish, Commonly, Titrations, Titration of commonly used
Medications To Be Avoided Or Used With Caution in ...
www.apdaparkinson.orgSaphris® Block dopamine receptors, but dissociate from the recep-tor more quickly than typical antipsychotics. They also tend to block serotonin receptors in addition to dopamine recep-tors. The result is less parkin-sonism than that caused by the typical antipsychotics. Antiemetics (used to treat nausea or vomiting) Chlorpromazine Droperidol
With, Used, Parish, Auction, Avoided, Avoided or used with caution
Medications Approved by the FDA for Bipolar Disorder
www.dbsalliance.orgMedication Brand Name Common side effects May interact with Aripiprazole Abilify® Insomnia Nausea Restlessness Tiredness Antidepressants such as Prozac or Paxil
LIST OF DIFFERENT GROUPS OF MEDICATIONS
www.cse.msu.edu(Saphris) is a 5 ‐HT2A and D2receptor antagonist under development for the treatment of schizophrenia and acute mania associated with bipolar disorder. • Paliperidone (Invega) ‐ Derivative of risperidone that was approved in 2006. • Iloperidone (Fanapt) ‐ Approved by the FDA
Aging Brain Care - UCLA GWEP
gwep.med.ucla.eduAsenapine Saphris™ Atenolol Tenormin™ Bupropion Wellbutrin™, Zyban™ Captopril Capoten™ Cetirizine Zyrtec™ Chlorthalidone Diuril™, Hygroton™ Cimetidine Tagamet™ Clidinium Librax™ Clorazepate Tranxene™ Codeine Contin™ Colchicine Colcrys™ Desloratadine Clarinex™ Diazepam Valium™ Digoxin Lanoxin™ Dipyridamole ...
GeneSight Psychotropic
genesight.comasenapine (Saphris®) cariprazine (Vraylar®) lumateperone (Caplyta®) lurasidone (Latuda®) paliperidone (Invega®) thiothixene (Navane®) ziprasidone (Geodon®) fluphenazine (Prolixin®) 1 olanzapine (Zyprexa ®) 1 quetiapine (Seroquel ®) 1 clozapine (Clozaril®) ®1,8 haloperidol (Haldol®) 1,8 chlorpromazine (Thorazine®) 1,6 aripiprazole ...
Information Sheet for Psychotropic Medications
guardianadlitem.orgSep 04, 2015 · o Saphris (Asenapine) o Latuda (Lurasidone) * Abilify, Seroquel, and lozapine come with “lack ox Warnings” by the Food and Drug Administration . This means the medication can cause serious undesirable effects (such as a fatal, life-threatening or permanently disabling adverse reaction) to the potential benefit from the drug;
Minimum Laboratory Monitoring For Psychotropic Medications
www.azcompletehealth.comWhite Blood Cell Count (WBC) w/ Absolute Neutrophil Count (ANC) Weekly for 1 st 6 months (if values within normal limits), then every 2 wks. for